Advertisement
YOU ARE HERE: LAT HomeCollectionsRaloxifene Hydrocloride Drug
IN THE NEWS

Raloxifene Hydrocloride Drug

FEATURED ARTICLES
CALIFORNIA | LOCAL
June 17, 1999 | From Times staff and wire reports
Raloxifene, a drug intended to combat bone loss, reduces the risk of breast cancer by 76% in post-menopausal women, doctors from UC San Francisco reported today in the Journal of the American Medical Assn. Raloxifene belongs to a group of drugs that mimic estrogen in some parts of the body and may therefore have some of estrogen's benefits.
ARTICLES BY DATE
CALIFORNIA | LOCAL
June 17, 1999 | From Times staff and wire reports
Raloxifene, a drug intended to combat bone loss, reduces the risk of breast cancer by 76% in post-menopausal women, doctors from UC San Francisco reported today in the Journal of the American Medical Assn. Raloxifene belongs to a group of drugs that mimic estrogen in some parts of the body and may therefore have some of estrogen's benefits.
Los Angeles Times Articles
|